

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.06636486 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.06636486 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.84043642 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.01936410 |
| 5 | * type I interferon signaling pathway (GO:0060337) | 4.96685465 |
| 6 | * cellular response to type I interferon (GO:0071357) | 4.96685465 |
| 7 | * response to type I interferon (GO:0034340) | 4.95386906 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.39220635 |
| 9 | response to interferon-beta (GO:0035456) | 4.33199119 |
| 10 | negative regulation of interleukin-12 production (GO:0032695) | 4.23298031 |
| 11 | response to interferon-alpha (GO:0035455) | 4.19489823 |
| 12 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.18324117 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 4.14902109 |
| 14 | cellular response to interferon-beta (GO:0035458) | 4.07346916 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.07018271 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.07018271 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.89795685 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 3.81140655 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.81104486 |
| 20 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76102144 |
| 21 | negative regulation of viral genome replication (GO:0045071) | 3.73208224 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.69412918 |
| 23 | positive regulation of antigen processing and presentation (GO:0002579) | 3.62832664 |
| 24 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.57355763 |
| 25 | regulation of RIG-I signaling pathway (GO:0039535) | 3.54361285 |
| 26 | detection of other organism (GO:0098543) | 3.52563586 |
| 27 | detection of bacterium (GO:0016045) | 3.52500388 |
| 28 | cellular response to exogenous dsRNA (GO:0071360) | 3.52141092 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.48701901 |
| 30 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.46708692 |
| 31 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.37271226 |
| 32 | positive regulation of type 2 immune response (GO:0002830) | 3.36153317 |
| 33 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33827159 |
| 34 | regulation of chronic inflammatory response (GO:0002676) | 3.32512304 |
| 35 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31117875 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.27717909 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24129842 |
| 38 | defense response to protozoan (GO:0042832) | 3.23972225 |
| 39 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.23241189 |
| 40 | natural killer cell mediated immunity (GO:0002228) | 3.23241189 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.22552639 |
| 42 | B cell mediated immunity (GO:0019724) | 3.22309260 |
| 43 | response to peptidoglycan (GO:0032494) | 3.21053426 |
| 44 | positive regulation of interferon-beta production (GO:0032728) | 3.19343282 |
| 45 | cellular response to virus (GO:0098586) | 3.18730877 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17298308 |
| 47 | cellular response to zinc ion (GO:0071294) | 3.16953140 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.11860518 |
| 49 | myeloid dendritic cell activation (GO:0001773) | 3.10657944 |
| 50 | myeloid dendritic cell differentiation (GO:0043011) | 3.05517751 |
| 51 | regulation of T cell tolerance induction (GO:0002664) | 3.05042958 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.04121712 |
| 53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03874595 |
| 54 | T cell migration (GO:0072678) | 3.00771956 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.00106191 |
| 56 | regulation of type 2 immune response (GO:0002828) | 2.98194207 |
| 57 | response to protozoan (GO:0001562) | 2.97785399 |
| 58 | ribosomal small subunit assembly (GO:0000028) | 2.97668179 |
| 59 | germinal center formation (GO:0002467) | 2.97471213 |
| 60 | lymphocyte chemotaxis (GO:0048247) | 2.97308039 |
| 61 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97053472 |
| 62 | regulation of response to interferon-gamma (GO:0060330) | 2.96842385 |
| 63 | detection of external biotic stimulus (GO:0098581) | 2.96273635 |
| 64 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.95866341 |
| 65 | negative regulation of innate immune response (GO:0045824) | 2.95588725 |
| 66 | regulation of viral genome replication (GO:0045069) | 2.94985651 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94641874 |
| 68 | response to host immune response (GO:0052572) | 2.94641874 |
| 69 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.93386218 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.91141864 |
| 71 | T-helper 1 type immune response (GO:0042088) | 2.90332682 |
| 72 | negative regulation of viral process (GO:0048525) | 2.89920450 |
| 73 | cellular response to interferon-gamma (GO:0071346) | 2.89862115 |
| 74 | positive regulation by symbiont of host defense response (GO:0052509) | 2.88446582 |
| 75 | modulation by symbiont of host defense response (GO:0052031) | 2.88446582 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.88446582 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.88446582 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.88446582 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.88446582 |
| 80 | positive regulation of interleukin-12 production (GO:0032735) | 2.87689685 |
| 81 | negative thymic T cell selection (GO:0045060) | 2.86863878 |
| 82 | cellular response to interferon-alpha (GO:0035457) | 2.86825535 |
| 83 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.85769009 |
| 84 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85315465 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84097392 |
| 86 | response to interferon-gamma (GO:0034341) | 2.83961316 |
| 87 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.83767622 |
| 88 | neutrophil activation (GO:0042119) | 2.83742600 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.82989006 |
| 90 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.82922752 |
| 91 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.82588290 |
| 92 | granulocyte activation (GO:0036230) | 2.82480975 |
| 93 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.80826567 |
| 94 | regulation of activation of Janus kinase activity (GO:0010533) | 2.79330716 |
| 95 | negative T cell selection (GO:0043383) | 2.79197211 |
| 96 | respiratory burst (GO:0045730) | 2.79195864 |
| 97 | regulation of natural killer cell differentiation (GO:0032823) | 2.78406375 |
| 98 | defense response to virus (GO:0051607) | 2.76469771 |
| 99 | regulation of chemokine biosynthetic process (GO:0045073) | 2.75827090 |
| 100 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.75295803 |
| 101 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.75022966 |
| 102 | positive regulation of defense response to virus by host (GO:0002230) | 2.73090740 |
| 103 | regulation of gamma-delta T cell activation (GO:0046643) | 2.71891509 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.71282819 |
| 105 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.70712997 |
| 106 | positive regulation of humoral immune response (GO:0002922) | 2.70622648 |
| 107 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69819943 |
| 108 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69652223 |
| 109 | regulation of tolerance induction (GO:0002643) | 2.66697375 |
| 110 | regulation of defense response to virus by host (GO:0050691) | 2.66441231 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 2.66283624 |
| 112 | dendritic cell differentiation (GO:0097028) | 2.66051992 |
| 113 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64949194 |
| 114 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.63202317 |
| 115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63142716 |
| 116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.58113779 |
| 117 | natural killer cell activation (GO:0030101) | 2.57405060 |
| 118 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.55271252 |
| 119 | regulation of hypersensitivity (GO:0002883) | 2.52876941 |
| 120 | cellular extravasation (GO:0045123) | 2.51641244 |
| 121 | regulation of interferon-beta production (GO:0032648) | 2.51177268 |
| 122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.49379026 |
| 123 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.48258327 |
| 124 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46501606 |
| 125 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46025446 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.45682207 |
| 127 | leukocyte mediated cytotoxicity (GO:0001909) | 2.45330412 |
| 128 | leukocyte aggregation (GO:0070486) | 2.45281889 |
| 129 | regulation of interleukin-12 production (GO:0032655) | 2.44538971 |
| 130 | positive regulation of interleukin-17 production (GO:0032740) | 2.43988374 |
| 131 | positive regulation of B cell differentiation (GO:0045579) | 2.43551122 |
| 132 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.41906665 |
| 133 | negative regulation of type I interferon production (GO:0032480) | 2.39783088 |
| 134 | myeloid cell activation involved in immune response (GO:0002275) | 2.38272427 |
| 135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.38225270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.66522018 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.93711160 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.72299588 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.55379589 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03619150 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.19439714 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89518065 |
| 8 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.82379942 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80247524 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71848344 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70698330 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51677006 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50098421 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.47795114 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.42866412 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29410998 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.26215695 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.15418750 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10629750 |
| 20 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06701863 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05023601 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95149080 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90747556 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90047537 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89965861 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.88923182 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86170145 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83864910 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.83170216 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79643177 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65095358 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.63161910 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62980330 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58802907 |
| 35 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.54099785 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52043698 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51827918 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51679743 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48954763 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48214826 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46164144 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44945885 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41954155 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41577948 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.41371921 |
| 46 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.41170054 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40533685 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38334279 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37251413 |
| 50 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36287744 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35887547 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34458831 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33011012 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31604688 |
| 55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31066924 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29026337 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28346727 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.27540210 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24778842 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24306353 |
| 61 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24104299 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.22792743 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21318585 |
| 64 | * MAF_26560356_Chip-Seq_TH2_Human | 1.20837818 |
| 65 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18405738 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16945853 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16689391 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16396678 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.15331230 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14376395 |
| 71 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12562520 |
| 72 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12294440 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12154892 |
| 74 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11989158 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11317445 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10800849 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10204898 |
| 78 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09378582 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09171784 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08613713 |
| 81 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07602308 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07257640 |
| 83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06269332 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05850452 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05292572 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03887634 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.03338731 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03312968 |
| 89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02816984 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02763152 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01319319 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00335196 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99608636 |
| 94 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96893231 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96456803 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.96331862 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96128084 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94863702 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.91666693 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90320157 |
| 101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.88934533 |
| 102 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88616264 |
| 103 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87915916 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87761167 |
| 105 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87615037 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84545359 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84544761 |
| 108 | P300_27268052_Chip-Seq_Bcells_Human | 0.84261110 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84017802 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.83915235 |
| 111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83665384 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83655300 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83402737 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82812657 |
| 115 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82675145 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82466848 |
| 117 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.82099043 |
| 118 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82012649 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80512901 |
| 120 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79776692 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79538174 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.79401430 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78385621 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77508471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.45061112 |
| 2 | MP0009785_altered_susceptibility_to | 3.65778673 |
| 3 | MP0003724_increased_susceptibility_to | 3.36553496 |
| 4 | MP0000685_abnormal_immune_system | 3.32766138 |
| 5 | MP0005671_abnormal_response_to | 3.11260727 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.99520242 |
| 7 | MP0003436_decreased_susceptibility_to | 2.82385599 |
| 8 | MP0005025_abnormal_response_to | 2.79979838 |
| 9 | MP0005387_immune_system_phenotype | 2.79259621 |
| 10 | MP0001790_abnormal_immune_system | 2.79259621 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.68741838 |
| 12 | MP0006082_CNS_inflammation | 2.53113886 |
| 13 | MP0001800_abnormal_humoral_immune | 2.52593893 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.38174130 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.36331381 |
| 16 | MP0002723_abnormal_immune_serum | 2.35870357 |
| 17 | MP0002419_abnormal_innate_immunity | 2.35805025 |
| 18 | MP0001819_abnormal_immune_cell | 2.17297688 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.14929084 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.14058688 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.11317480 |
| 22 | MP0002006_tumorigenesis | 2.09790761 |
| 23 | MP0010155_abnormal_intestine_physiology | 1.94797413 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.88945255 |
| 25 | MP0003303_peritoneal_inflammation | 1.86843251 |
| 26 | MP0001853_heart_inflammation | 1.84948252 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.82641925 |
| 28 | MP0004947_skin_inflammation | 1.81691778 |
| 29 | MP0002405_respiratory_system_inflammati | 1.79636734 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.78803898 |
| 31 | MP0004510_myositis | 1.75121294 |
| 32 | MP0009764_decreased_sensitivity_to | 1.74479125 |
| 33 | MP0002398_abnormal_bone_marrow | 1.73099934 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.72876080 |
| 35 | MP0000716_abnormal_immune_system | 1.72490502 |
| 36 | MP0008469_abnormal_protein_level | 1.68626071 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.62346546 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.57961289 |
| 39 | MP0001873_stomach_inflammation | 1.51942742 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.49296630 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.49296630 |
| 42 | MP0009840_abnormal_foam_cell | 1.48153552 |
| 43 | MP0002429_abnormal_blood_cell | 1.44797389 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.42408423 |
| 45 | MP0002722_abnormal_immune_system | 1.41653543 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.40242643 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.35710780 |
| 48 | MP0003186_abnormal_redox_activity | 1.35346457 |
| 49 | MP0000858_altered_metastatic_potential | 1.35310448 |
| 50 | MP0005451_abnormal_body_composition | 1.30942241 |
| 51 | MP0005310_abnormal_salivary_gland | 1.26233678 |
| 52 | MP0005360_urolithiasis | 1.26010794 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.25666011 |
| 54 | MP0003448_altered_tumor_morphology | 1.23054447 |
| 55 | MP0000604_amyloidosis | 1.20989324 |
| 56 | MP0003866_abnormal_defecation | 1.19842643 |
| 57 | MP0002254_reproductive_system_inflammat | 1.19792762 |
| 58 | MP0000343_altered_response_to | 1.13414390 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.07434971 |
| 60 | MP0009763_increased_sensitivity_to | 1.07309226 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.07178753 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.03691342 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 1.03621389 |
| 64 | MP0002132_abnormal_respiratory_system | 1.01984820 |
| 65 | MP0000490_abnormal_crypts_of | 1.00813506 |
| 66 | MP0003195_calcinosis | 0.99812665 |
| 67 | MP0009278_abnormal_bone_marrow | 0.95740633 |
| 68 | MP0008004_abnormal_stomach_pH | 0.95281721 |
| 69 | MP0002933_joint_inflammation | 0.95022019 |
| 70 | MP0000703_abnormal_thymus_morphology | 0.94847969 |
| 71 | MP0003690_abnormal_glial_cell | 0.93547419 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 0.91846407 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 0.91210572 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 0.89445602 |
| 75 | MP0002163_abnormal_gland_morphology | 0.88888545 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.88441696 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.88421714 |
| 78 | MP0005365_abnormal_bile_salt | 0.86315342 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.86248879 |
| 80 | MP0005083_abnormal_biliary_tract | 0.85374117 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.85061652 |
| 82 | MP0005164_abnormal_response_to | 0.84888521 |
| 83 | MP0000609_abnormal_liver_physiology | 0.84856029 |
| 84 | MP0010307_abnormal_tumor_latency | 0.83261629 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.81582597 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.81412913 |
| 87 | MP0001542_abnormal_bone_strength | 0.80274704 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.79643047 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.79586013 |
| 90 | MP0003828_pulmonary_edema | 0.79419839 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.77004423 |
| 92 | MP0003075_altered_response_to | 0.76463428 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.75042434 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74219425 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.73718619 |
| 96 | MP0004883_abnormal_blood_vessel | 0.73677517 |
| 97 | MP0000249_abnormal_blood_vessel | 0.72384134 |
| 98 | MP0003045_fibrosis | 0.72334559 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.72113311 |
| 100 | MP0005165_increased_susceptibility_to | 0.71651856 |
| 101 | MP0008260_abnormal_autophagy | 0.71391654 |
| 102 | MP0005023_abnormal_wound_healing | 0.70880516 |
| 103 | MP0003252_abnormal_bile_duct | 0.70609494 |
| 104 | MP0001764_abnormal_homeostasis | 0.70489046 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.69462176 |
| 106 | MP0005166_decreased_susceptibility_to | 0.68711929 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.68650600 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.68596820 |
| 109 | MP0006054_spinal_hemorrhage | 0.67981217 |
| 110 | MP0005390_skeleton_phenotype | 0.67437359 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.65029057 |
| 112 | MP0008874_decreased_physiological_sensi | 0.64719080 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.63899540 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62743019 |
| 115 | MP0000598_abnormal_liver_morphology | 0.62586227 |
| 116 | MP0001851_eye_inflammation | 0.62472606 |
| 117 | MP0001663_abnormal_digestive_system | 0.60691347 |
| 118 | MP0003795_abnormal_bone_structure | 0.60588089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.07173052 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.01632571 |
| 3 | Autoimmune thrombocytopenia (HP:0001973) | 4.69668800 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.59421952 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.38238291 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.38238291 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.38238291 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.27125684 |
| 9 | Chronic otitis media (HP:0000389) | 4.04633766 |
| 10 | Myositis (HP:0100614) | 3.95499562 |
| 11 | Increased IgM level (HP:0003496) | 3.79875411 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.73807606 |
| 13 | Recurrent fungal infections (HP:0002841) | 3.60313900 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.47255343 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 3.43782144 |
| 16 | Vasculitis (HP:0002633) | 3.39762164 |
| 17 | Recurrent viral infections (HP:0004429) | 3.36807890 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.32235267 |
| 19 | Pustule (HP:0200039) | 3.31269078 |
| 20 | Orchitis (HP:0100796) | 3.28626896 |
| 21 | Nasal polyposis (HP:0100582) | 3.27378111 |
| 22 | Recurrent skin infections (HP:0001581) | 3.24014691 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.23961510 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.10205624 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 3.09747264 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.08248330 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.08248330 |
| 28 | Loss of speech (HP:0002371) | 3.03775343 |
| 29 | Thrombocytosis (HP:0001894) | 3.02021005 |
| 30 | Hypergammaglobulinemia (HP:0010702) | 3.01033109 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.96196844 |
| 32 | Abnormality of T cell number (HP:0011839) | 2.93122686 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.92490824 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.91186471 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.90280918 |
| 36 | Optic neuritis (HP:0100653) | 2.90280918 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.84306698 |
| 38 | Abnormality of T cells (HP:0002843) | 2.82600975 |
| 39 | Basal ganglia calcification (HP:0002135) | 2.78677342 |
| 40 | Petechiae (HP:0000967) | 2.77610940 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.76319454 |
| 42 | Periodontitis (HP:0000704) | 2.72693684 |
| 43 | Gangrene (HP:0100758) | 2.68870326 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.63225270 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.62157908 |
| 46 | Stomatitis (HP:0010280) | 2.61638141 |
| 47 | Gingivitis (HP:0000230) | 2.59785751 |
| 48 | IgG deficiency (HP:0004315) | 2.58418156 |
| 49 | T lymphocytopenia (HP:0005403) | 2.57719612 |
| 50 | IgM deficiency (HP:0002850) | 2.57510160 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55292291 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.54016347 |
| 53 | Chronic diarrhea (HP:0002028) | 2.53295854 |
| 54 | Meningitis (HP:0001287) | 2.49662873 |
| 55 | Gingival bleeding (HP:0000225) | 2.49414904 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.45318882 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.45318882 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.45318882 |
| 59 | Leukocytosis (HP:0001974) | 2.44191033 |
| 60 | Cellulitis (HP:0100658) | 2.43280219 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.42181235 |
| 62 | Increased IgE level (HP:0003212) | 2.39785208 |
| 63 | Urticaria (HP:0001025) | 2.39557373 |
| 64 | Eosinophilia (HP:0001880) | 2.39102441 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.36482376 |
| 66 | Obstructive lung disease (HP:0006536) | 2.35875374 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35875374 |
| 68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35170781 |
| 69 | Progressive neurologic deterioration (HP:0002344) | 2.33418367 |
| 70 | Hepatosplenomegaly (HP:0001433) | 2.32706928 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.31865410 |
| 72 | Abnormality of B cell number (HP:0010975) | 2.31525636 |
| 73 | Hemoptysis (HP:0002105) | 2.31322759 |
| 74 | Pulmonary embolism (HP:0002204) | 2.30627380 |
| 75 | Chronic sinusitis (HP:0011109) | 2.27453610 |
| 76 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27019470 |
| 77 | Mucopolysacchariduria (HP:0008155) | 2.27019470 |
| 78 | Lymphopenia (HP:0001888) | 2.26912596 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.25512279 |
| 80 | Tetraparesis (HP:0002273) | 2.25162085 |
| 81 | Granulocytopenia (HP:0001913) | 2.23629744 |
| 82 | Abnormality of the pericardium (HP:0001697) | 2.23232818 |
| 83 | Joint swelling (HP:0001386) | 2.22944304 |
| 84 | Chest pain (HP:0100749) | 2.22920378 |
| 85 | IgA deficiency (HP:0002720) | 2.22888650 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.22690752 |
| 87 | Inflammation of the large intestine (HP:0002037) | 2.21735752 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 2.21673509 |
| 89 | Arterial thrombosis (HP:0004420) | 2.21340135 |
| 90 | Amyloidosis (HP:0011034) | 2.19467391 |
| 91 | Epistaxis (HP:0000421) | 2.19295591 |
| 92 | Polyneuropathy (HP:0001271) | 2.18760835 |
| 93 | Disinhibition (HP:0000734) | 2.18413971 |
| 94 | Severe combined immunodeficiency (HP:0004430) | 2.17803270 |
| 95 | Purpura (HP:0000979) | 2.17171222 |
| 96 | Colitis (HP:0002583) | 2.15322908 |
| 97 | Episodic fever (HP:0001954) | 2.14310805 |
| 98 | Osteomyelitis (HP:0002754) | 2.11675787 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.11067505 |
| 100 | Malnutrition (HP:0004395) | 2.09779440 |
| 101 | Gastrointestinal inflammation (HP:0004386) | 2.09524634 |
| 102 | Hypertensive crisis (HP:0100735) | 2.09358730 |
| 103 | Glomerulonephritis (HP:0000099) | 2.08505018 |
| 104 | Anorexia (HP:0002039) | 2.08290949 |
| 105 | Skin ulcer (HP:0200042) | 2.08055626 |
| 106 | Encephalitis (HP:0002383) | 2.07857225 |
| 107 | Arthralgia (HP:0002829) | 2.07374349 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05860453 |
| 109 | Skin rash (HP:0000988) | 2.03410775 |
| 110 | B lymphocytopenia (HP:0010976) | 2.02751564 |
| 111 | Thyroiditis (HP:0100646) | 2.02397940 |
| 112 | Glomerulopathy (HP:0100820) | 2.02378805 |
| 113 | Emphysema (HP:0002097) | 2.02108733 |
| 114 | Hematochezia (HP:0002573) | 2.01492390 |
| 115 | Recurrent lower respiratory tract infections (HP:0002783) | 2.01429775 |
| 116 | Increased serum ferritin (HP:0003281) | 2.00816391 |
| 117 | Recurrent pneumonia (HP:0006532) | 2.00383775 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.98044233 |
| 119 | Joint hemorrhage (HP:0005261) | 1.97986417 |
| 120 | Poor head control (HP:0002421) | 1.96578614 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.96390310 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.95078874 |
| 123 | Myocardial infarction (HP:0001658) | 1.91719078 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.91082642 |
| 125 | Nausea (HP:0002018) | 1.88483767 |
| 126 | Prolonged bleeding time (HP:0003010) | 1.87430353 |
| 127 | Bronchitis (HP:0012387) | 1.86233371 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.85104506 |
| 129 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84232865 |
| 130 | Cheilitis (HP:0100825) | 1.83418823 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.83111440 |
| 132 | Microcytic anemia (HP:0001935) | 1.83015192 |
| 133 | Pallor (HP:0000980) | 1.83012860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.53726360 |
| 2 | TYK2 | 3.48685806 |
| 3 | TBK1 | 3.45020742 |
| 4 | MAP4K1 | 3.40145065 |
| 5 | IKBKE | 3.19750512 |
| 6 | JAK3 | 2.90592742 |
| 7 | NME2 | 2.75611198 |
| 8 | BLK | 2.66009067 |
| 9 | TXK | 2.45132903 |
| 10 | KIT | 2.44864459 |
| 11 | FGFR4 | 2.42906808 |
| 12 | PIM2 | 2.42854470 |
| 13 | IRAK4 | 2.37688394 |
| 14 | IKBKB | 2.21613290 |
| 15 | JAK1 | 2.19036525 |
| 16 | IRAK3 | 2.17947918 |
| 17 | ERN1 | 2.16709162 |
| 18 | ZAP70 | 2.00438849 |
| 19 | TAOK2 | 1.88436275 |
| 20 | KDR | 1.76142571 |
| 21 | MST4 | 1.71212766 |
| 22 | TEC | 1.57841634 |
| 23 | CSK | 1.51188891 |
| 24 | PRPF4B | 1.50762453 |
| 25 | TAOK1 | 1.42446947 |
| 26 | SYK | 1.42166122 |
| 27 | BTK | 1.41230993 |
| 28 | NEK9 | 1.36859693 |
| 29 | PBK | 1.36706145 |
| 30 | TNK2 | 1.35583744 |
| 31 | BMPR2 | 1.31790803 |
| 32 | CHUK | 1.28337373 |
| 33 | FGR | 1.20954739 |
| 34 | TAOK3 | 1.20879275 |
| 35 | MAP3K13 | 1.20198197 |
| 36 | RPS6KA4 | 1.20027089 |
| 37 | NLK | 1.19478934 |
| 38 | EPHA3 | 1.18914884 |
| 39 | FGFR3 | 1.18547929 |
| 40 | RIPK4 | 1.17531229 |
| 41 | TGFBR2 | 1.13213817 |
| 42 | FLT3 | 1.10924351 |
| 43 | STK10 | 1.10699023 |
| 44 | PIM1 | 1.09823151 |
| 45 | LCK | 1.09397746 |
| 46 | CSF1R | 1.06005635 |
| 47 | EPHB1 | 1.04347559 |
| 48 | LYN | 0.98589726 |
| 49 | LRRK2 | 0.98126571 |
| 50 | HCK | 0.97802900 |
| 51 | SIK3 | 0.96024064 |
| 52 | MATK | 0.93425527 |
| 53 | EIF2AK1 | 0.92860946 |
| 54 | ITK | 0.92567387 |
| 55 | JAK2 | 0.90596300 |
| 56 | DDR2 | 0.88993330 |
| 57 | EIF2AK2 | 0.88778028 |
| 58 | MAP3K11 | 0.87230492 |
| 59 | MOS | 0.84978218 |
| 60 | MST1R | 0.83328917 |
| 61 | TGFBR1 | 0.83249412 |
| 62 | TRPM7 | 0.83137625 |
| 63 | CDC42BPA | 0.81532486 |
| 64 | STK4 | 0.76577969 |
| 65 | EIF2AK3 | 0.72274985 |
| 66 | MAP2K3 | 0.69848615 |
| 67 | TESK1 | 0.69617260 |
| 68 | FRK | 0.67201902 |
| 69 | PIK3CG | 0.63336652 |
| 70 | NUAK1 | 0.62764158 |
| 71 | MAPK11 | 0.62481353 |
| 72 | GRK6 | 0.61549801 |
| 73 | ACVR1B | 0.60194598 |
| 74 | ARAF | 0.58371556 |
| 75 | IRAK1 | 0.57940460 |
| 76 | ABL2 | 0.56695683 |
| 77 | SIK2 | 0.56309012 |
| 78 | PRKCD | 0.55495485 |
| 79 | NME1 | 0.55262954 |
| 80 | IRAK2 | 0.55172882 |
| 81 | MARK3 | 0.54229401 |
| 82 | RPS6KB2 | 0.54221551 |
| 83 | TIE1 | 0.53760759 |
| 84 | PDK1 | 0.53001201 |
| 85 | PRKG2 | 0.51486587 |
| 86 | PTK6 | 0.50752954 |
| 87 | MYLK | 0.50187781 |
| 88 | TLK1 | 0.50130378 |
| 89 | PRKCQ | 0.49219686 |
| 90 | MAP3K3 | 0.46730939 |
| 91 | MAPK7 | 0.45725835 |
| 92 | MAPKAPK2 | 0.43531689 |
| 93 | STK24 | 0.42987711 |
| 94 | FES | 0.42835686 |
| 95 | ABL1 | 0.42307610 |
| 96 | STK16 | 0.41478191 |
| 97 | PDPK1 | 0.41326879 |
| 98 | MAP3K5 | 0.40771406 |
| 99 | VRK1 | 0.40497652 |
| 100 | TESK2 | 0.39661452 |
| 101 | MAP2K6 | 0.39252393 |
| 102 | RPS6KA5 | 0.39169058 |
| 103 | CAMKK2 | 0.38835989 |
| 104 | PASK | 0.38768752 |
| 105 | BCKDK | 0.37964778 |
| 106 | ADRBK2 | 0.37065412 |
| 107 | PRKD2 | 0.36377714 |
| 108 | MAPKAPK3 | 0.36217415 |
| 109 | FYN | 0.36053718 |
| 110 | DAPK1 | 0.34720997 |
| 111 | MAP2K2 | 0.34356435 |
| 112 | MAP3K1 | 0.33684589 |
| 113 | RIPK1 | 0.31165742 |
| 114 | GRK7 | 0.30585647 |
| 115 | DAPK3 | 0.30140906 |
| 116 | DAPK2 | 0.29975299 |
| 117 | MAPK4 | 0.28731507 |
| 118 | BMX | 0.28519267 |
| 119 | TRIB3 | 0.26646784 |
| 120 | HIPK2 | 0.25696912 |
| 121 | ZAK | 0.25605884 |
| 122 | MAP3K12 | 0.24954569 |
| 123 | TTN | 0.24800346 |
| 124 | PKN1 | 0.23641914 |
| 125 | SMG1 | 0.21851902 |
| 126 | INSR | 0.19458697 |
| 127 | MAPK3 | 0.16518808 |
| 128 | CDK4 | 0.15954114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.23143798 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.90381643 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.87429321 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71199590 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.67777303 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63865784 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.57486834 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53418836 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.45651263 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.31211632 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.12396850 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10813800 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07698101 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.01339458 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.93035328 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.86919978 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.84004664 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.80421546 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.80268235 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.72748425 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71237642 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60788916 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58902897 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.49380541 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47823943 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47758808 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46272953 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46126326 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40697887 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40433721 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.33522514 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32612278 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32124554 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.30872677 |
| 35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.26863081 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22368998 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20995284 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19588813 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.19313268 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12582627 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12239830 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.11885501 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10775289 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.01902331 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.97753541 |
| 46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96573520 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.93691245 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88253055 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86405202 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85109734 |
| 51 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82682669 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 0.82218709 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81273380 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80429336 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.78883380 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76758808 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76236031 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.73818150 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73028733 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70054963 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70015427 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69534290 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.67303556 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66027705 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64717231 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63978307 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63496628 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62029713 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60240331 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60126200 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59231390 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.55243370 |
| 73 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.55220150 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.54742719 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54420500 |
| 76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54031183 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52421239 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51959044 |
| 79 | Protein export_Homo sapiens_hsa03060 | 0.51931885 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50162845 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48760573 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.48453488 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47756123 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.46733152 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.45801758 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.44245779 |
| 87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43501506 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42750315 |
| 89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42059970 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42019134 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41836131 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41095467 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39552891 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38980010 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.38904325 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38762161 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38640347 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38336289 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38063008 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36024686 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35336614 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34811259 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33900468 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32627374 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.32607074 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32511551 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31703882 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29701750 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29369429 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28258294 |
| 111 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26524012 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.26286086 |
| 113 | RNA polymerase_Homo sapiens_hsa03020 | 0.26204701 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26199507 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.21119545 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18988009 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.17424007 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.17289523 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.15891208 |
| 120 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13653365 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12255190 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11259637 |
| 123 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.09995712 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.09040424 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05572632 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.04417366 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04237747 |

